Leveraging The Collaborative Image Management Platform, HALO Link, For Multi-Site Image Analysis Collaborations
Date: 3 December 2021
Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT
Location: Webinar
Summary
Learning Objectives
- How the Pharma Services team at Indica Labs uses HALO Link to collaborate with customers, to launch and display image analysis results, and to archive studies
- About the flexible architecture of HALO Link that meets a wide variety of study and organizational needspatients
- How HALO and HALO AI are integrated with HALO Link for remote image analysis
Presenters
Doug Bowman
VP Pharma Services
Indica Labs
Doug is responsible for Indica Labs’ Pharma Services group which provides quantitative histopathology image analysis services to support customer’s preclinical and clinical biomarker assays. He also develops strategic business relationships to support the services business. Prior to Indica Labs, he spent 12+ years at Takeda Pharmaceuticals where he developed and expanded the tissue-based imaging capabilities to support early discovery, translational, and clinical programs. He was a key member of a team responsible for building a digital pathology laboratory that integrated LIMs, immunohistochemistry, slide scanners, and quantitative image analysis in an automated workflow. Doug has a BSE in biomedical and electrical engineering from Duke University.
William Edelman
Imaging Scientist
Indica Labs
Bill is an Imaging Scientist with Indica Labs’ Pharma Services group who is responsible for leading image analysis projects. He supports customers’ preclinical and clinical biomarker assays with high multi-parametric data. By using data visualization, statistical and informatics tools, and dimensionality-reduction techniques, he focuses on delivering high-quality project data and deliverables. He earned his PhD in Genome Sciences at the University of Washington where he used mass spectrometry-based proteomics to understand Parkinson’s disease cell signaling. His post-doctoral training focused on understanding neurodegeneration using patient-derived induced stem cells, transcriptomics, fluorescence microscopy and flow cytometry.